• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.使用天然分馏的 Panc-1 细胞系鉴定胰腺癌患者血清中的自身抗体。
Cancer Biomark. 2010;7(1):25-37. doi: 10.3233/CBM-2010-0145.
2
The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.使用天然蛋白质微阵列鉴定胰腺癌患者血清中的磷酸甘油酸激酶-1和组蛋白H4自身抗体。
Electrophoresis. 2009 Jun;30(12):2215-26. doi: 10.1002/elps.200800857.
3
Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.用于鉴定血清中可诱导体液免疫反应的肺癌抗原的整合蛋白微阵列。
Mol Cell Proteomics. 2008 Feb;7(2):268-81. doi: 10.1074/mcp.M700366-MCP200. Epub 2007 Oct 4.
4
Novel Autoantibody Signatures in Sera of Patients with Pancreatic Cancer, Chronic Pancreatitis and Autoimmune Pancreatitis: A Protein Microarray Profiling Approach.胰腺癌、慢性胰腺炎和自身免疫性胰腺炎患者血清中的新型自身抗体特征:一种蛋白质微阵列分析方法。
Int J Mol Sci. 2020 Mar 31;21(7):2403. doi: 10.3390/ijms21072403.
5
An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.胰腺癌中针对钙网蛋白异构体的自身抗体介导的免疫反应。
Cancer Res. 2004 Aug 1;64(15):5504-10. doi: 10.1158/0008-5472.CAN-04-0077.
6
Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens.基于对肿瘤抗原的抗体反应开发用于诊断癌症的天然蛋白质微阵列。
J Proteome Res. 2004 Mar-Apr;3(2):261-7. doi: 10.1021/pr049971u.
7
Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity.肿瘤细胞衍生蛋白的微阵列揭示了前列腺癌血清免疫反应的独特模式。
Proteomics. 2003 Nov;3(11):2200-7. doi: 10.1002/pmic.200300611.
8
Enhanced detection of autoantibodies on protein microarrays using a modified protein digestion technique.使用改良的蛋白质消化技术增强蛋白质微阵列上自身抗体的检测。
J Proteome Res. 2008 Jun;7(6):2553-61. doi: 10.1021/pr800023g. Epub 2008 May 2.
9
Calreticulin is a B cell molecular target in some gastrointestinal malignancies.钙网织蛋白是一些胃肠道恶性肿瘤中的 B 细胞分子靶点。
Clin Exp Immunol. 2010 May;160(2):215-22. doi: 10.1111/j.1365-2249.2009.04085.x. Epub 2009 Dec 17.
10
Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.循环抗MUC1 IgG抗体作为胰腺癌的一个有利预后因素。
Int J Cancer. 2003 Jan 1;103(1):97-100. doi: 10.1002/ijc.10801.

引用本文的文献

1
Plasma cells in human pancreatic ductal adenocarcinoma secrete antibodies against self-antigens.人类胰腺导管腺癌中的浆细胞分泌针对自身抗原的抗体。
JCI Insight. 2023 Nov 8;8(21):e172449. doi: 10.1172/jci.insight.172449.
2
KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer.KIF15 对于 USP10 介导的 PGK1 去泛素化在胰腺癌糖酵解过程中是必不可少的。
Cell Death Dis. 2023 Feb 17;14(2):137. doi: 10.1038/s41419-023-05679-2.
3
B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma.B淋巴细胞在胰腺腺癌病理生理学中的作用
Front Immunol. 2022 Mar 14;13:867902. doi: 10.3389/fimmu.2022.867902. eCollection 2022.
4
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer.糖酵解途径作为胰腺癌新型肿瘤免疫治疗的靶点。
Molecules. 2021 Mar 15;26(6):1642. doi: 10.3390/molecules26061642.
5
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers.胰腺癌新型代谢亚型的综合分析促进了新的预后生物标志物的发现。
Front Oncol. 2019 Feb 27;9:115. doi: 10.3389/fonc.2019.00115. eCollection 2019.
6
Glucose metabolic phenotype of pancreatic cancer.胰腺癌的葡萄糖代谢表型
World J Gastroenterol. 2016 Mar 28;22(12):3471-85. doi: 10.3748/wjg.v22.i12.3471.
7
A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.血清自身抗体作为胰腺癌检测生物标志物的系统评价。
Oncotarget. 2016 Mar 8;7(10):11151-64. doi: 10.18632/oncotarget.7098.
8
Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.血清胰腺癌抗原自身抗体作为旧金山湾区病例对照研究中胰腺癌的生物标志物。
Cancer. 2012 Nov 1;118(21):5384-94. doi: 10.1002/cncr.27538. Epub 2012 Apr 19.

本文引用的文献

1
Identifying autoantibody signatures in cancer: a promising challenge.识别癌症中的自身抗体特征:一项充满前景的挑战。
Expert Rev Proteomics. 2009 Aug;6(4):377-86. doi: 10.1586/epr.09.56.
2
Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.鉴定一组与年轻女性乳腺原位癌存在相关的新型血清自身抗体。
Clin Cancer Res. 2009 Jul 15;15(14):4733-41. doi: 10.1158/1078-0432.CCR-08-3307. Epub 2009 Jul 7.
3
The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray.使用天然蛋白质微阵列鉴定胰腺癌患者血清中的磷酸甘油酸激酶-1和组蛋白H4自身抗体。
Electrophoresis. 2009 Jun;30(12):2215-26. doi: 10.1002/elps.200800857.
4
Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arrays.使用构象蛋白质阵列对非小细胞肺癌患者和健康供体的抗体反应进行血清学分析。
J Immunol Methods. 2009 Feb 28;341(1-2):50-8. doi: 10.1016/j.jim.2008.10.016. Epub 2008 Nov 28.
5
Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.利用蛋白质组学方法鉴定肿瘤相关抗原作为肝细胞癌的标志物。
J Proteome Res. 2008 Sep;7(9):4004-12. doi: 10.1021/pr800273h. Epub 2008 Aug 2.
6
PGK1 a potential marker for peritoneal dissemination in gastric cancer.PGK1:一种胃癌腹膜播散的潜在标志物。
Cell Physiol Biochem. 2008;21(5-6):429-36. doi: 10.1159/000129635. Epub 2008 Apr 24.
7
A glycolytic mechanism regulating an angiogenic switch in prostate cancer.一种调节前列腺癌血管生成开关的糖酵解机制。
Cancer Res. 2007 Jan 1;67(1):149-59. doi: 10.1158/0008-5472.CAN-06-2971.
8
Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.Wnt-5a的表达通过刺激细胞迁移和侵袭与胃癌的侵袭性相关。
Cancer Res. 2006 Nov 1;66(21):10439-48. doi: 10.1158/0008-5472.CAN-06-2359.
9
Tumor-associated antigen arrays for the serological diagnosis of cancer.用于癌症血清学诊断的肿瘤相关抗原阵列
Mol Cell Proteomics. 2006 Oct;5(10):1745-59. doi: 10.1074/mcp.R600010-MCP200. Epub 2006 May 29.
10
Outlier sums for differential gene expression analysis.差异基因表达分析的异常值总和
Biostatistics. 2007 Jan;8(1):2-8. doi: 10.1093/biostatistics/kxl005. Epub 2006 May 15.

使用天然分馏的 Panc-1 细胞系鉴定胰腺癌患者血清中的自身抗体。

The identification of auto-antibodies in pancreatic cancer patient sera using a naturally fractionated Panc-1 cell line.

机构信息

Department of Chemistry, The University of Michigan, Ann Arbor, MI, USA.

出版信息

Cancer Biomark. 2010;7(1):25-37. doi: 10.3233/CBM-2010-0145.

DOI:10.3233/CBM-2010-0145
PMID:21045262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3130890/
Abstract

The immunogenic nature of cancer can be explored to distinguish pancreatic cancer from related non-cancer conditions. We describe a liquid-based microarray approach followed by statistical analysis and confirmation for discovery of auto-immune biomarkers for pancreatic cancer. Proteins from the Panc-1 pancreatic cancer cell line were fractionated using a 2-D liquid separation method into over 1052 fractions and spotted onto nitrocellulose coated glass slides. The slides were hybridized with 37 pancreatic cancer sera, 24 chronic pancreatitis sera and 23 normal sera to detect elevated levels of reactivity against the proteins in spotted fractions. The response data obtained from protein microarrays was first analyzed by Wilcoxon Rank-Sum Tests to generate two lists of fractions that positively responded to the cancer sera and showed p-values less than 0.02 in the pairwise comparison between cancer specimens and normal and chronic pancreatitis specimens. The top 3 fractions with the lowest correlations were combined in receiver operating characteristic analyses. The area-under-the-curve (AUC) values are 0.813 and 0.792 for cancer vs. normal and cancer vs. pancreatitis respectively. Outlier-Sum statistics were then applied to the microarray data to determine the existence of outliers exclusive in cancer sera. The selected fractions were identified by LC-MS/MS. We further confirmed the occurrence of outliers with three proteins among cancer samples in a confirmation experiment using a separate dataset of 165 serum samples containing 48 cancer sera and 117 non-cancer controls. Phosphoglycerate kinase 1 (PGK1) elicited greater reactivity in 20.9% (10 in 48) of the samples in the cancer group, while no outlier was present in the non-cancer groups.

摘要

癌症的免疫原性可用于区分胰腺癌与相关非癌性疾病。我们描述了一种基于液体的微阵列方法,随后进行了统计分析和确证,以发现胰腺癌的自身免疫生物标志物。使用二维液体分离方法将来自 Panc-1 胰腺癌细胞系的蛋白质分离成 1052 多个馏分,并点样到硝酸纤维素涂层的玻璃载玻片上。将载玻片与 37 份胰腺癌血清、24 份慢性胰腺炎血清和 23 份正常血清杂交,以检测斑点馏分中针对蛋白质的反应性升高。从蛋白质微阵列获得的反应数据首先通过 Wilcoxon 秩和检验进行分析,以生成两组分数,这些分数对癌症血清呈阳性反应,并且在癌症标本与正常和慢性胰腺炎标本之间的两两比较中 p 值小于 0.02。将相关性最低的前 3 个分数合并进行接受者操作特征分析。曲线下面积 (AUC) 值分别为 0.813 和 0.792,用于癌症与正常和癌症与胰腺炎的比较。然后对微阵列数据应用离群和总和统计,以确定仅在癌症血清中存在离群值。通过 LC-MS/MS 鉴定选定的分数。我们在使用包含 48 份癌症血清和 117 份非癌症对照的 165 份血清样本的独立数据集的确认实验中,进一步证实了三种蛋白质在癌症样本中离群值的发生。磷酸甘油酸激酶 1(PGK1)在癌症组的 20.9%(48 份样本中的 10 份)中引起更大的反应性,而在非癌症组中没有离群值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/3f7430b8e8cc/nihms303139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/48c85a4d4326/nihms303139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/005c2ff77610/nihms303139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/be43151b6395/nihms303139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/9a915e76a24f/nihms303139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/3f7430b8e8cc/nihms303139f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/48c85a4d4326/nihms303139f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/005c2ff77610/nihms303139f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/be43151b6395/nihms303139f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/9a915e76a24f/nihms303139f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee05/3130890/3f7430b8e8cc/nihms303139f5.jpg